Mode
Text Size
Log in / Sign up

PRKRA gene variants linked to tinnitus and mild cognitive impairmentGene Variants Linked to Tinnitus and Memory Problems

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Interpret with caution: PRKRA gene variants were associated with MCI in tinnitus patients, but evidence is preliminary.

This randomized controlled trial included 294 adults with chronic tinnitus recruited from five European clinics. The study aimed to investigate the association between rare loss-of-function and structural variants in the PRKRA gene and the presence of mild cognitive impairment (MCI) in this population. No comparator group was reported, and the primary outcome was not specified.

The main finding was an enrichment of rare loss-of-function variants in PRKRA among patients with MCI: 15% of MCI patients carried such variants. Additionally, cognitive performance was linked to tinnitus in patients with MCI gene variants, particularly PRKRA, but not to hyperacusis or high frequency hearing loss. Effect sizes, absolute numbers, and p-values were not reported.

Safety data, including adverse events and tolerability, were not reported. Limitations were also not reported, but the study's certainty is low due to the small sample size and lack of replication. The authors note that this is an association only, and no causation is established.

Clinicians should interpret these findings with caution. The results suggest a potential genetic link between PRKRA variants and tinnitus-associated cognitive impairment, but the evidence is preliminary and not ready for clinical application. Further studies are needed to confirm these associations.

A new study looked at whether certain gene variants might link chronic tinnitus to mild cognitive impairment (MCI). Researchers analyzed the DNA of 294 adults with chronic tinnitus from five European clinics. They focused on rare loss-of-function variants in the PRKRA gene.

The study found that 15% of participants with both tinnitus and MCI had these rare variants. Among those with the variants, cognitive performance was linked to tinnitus severity, but not to other hearing issues like hyperacusis or high-frequency hearing loss.

This is an early finding. The study was small and has not been repeated. The results show an association, not proof that the gene variants cause tinnitus or MCI. No safety concerns were reported because this was a genetic analysis, not a treatment trial.

For now, this research offers a clue for future studies. It does not change current care for tinnitus or MCI. If you have tinnitus or memory concerns, talk to your doctor about proven management strategies.

What this means for you:
Rare PRKRA gene variants may link tinnitus and mild cognitive impairment, but more research is needed.

Study Details

Study typeRct
Sample sizen = 294
EvidenceLevel 2
PublishedMay 2026
View Original Abstract ↓
BACKGROUND: Genetics underlying the co-occurrence of tinnitus and mild cognitive impairment (MCI) is unknown. METHODS: Adults with chronic tinnitus from five European clinics participated in a randomized controlled trial (N=294). They underwent deep phenotyping and blood sampling for genome sequencing. A subset with MCI (N=75) were analyzed for gene burden and structural variations. RESULTS: The PRKRA gene showed an enrichment of rare loss-of-function variants in 15% of MCI patients, associated with mild-to-moderate tinnitus. Cognitive performance was linked to tinnitus, but not hyperacusis or high frequency hearing loss (HFHL), in patients with MCI gene variants, especially PRKRA. This association was independent of the APOE {epsilon}4 genotype. Protein modeling indicated that mutant PACT (PRKRA) lacking the dsRBM3 domain bound PKR with increased affinity. CONCLUSIONS: Rare mutations in PRKRA are linked to tinnitus and MCI, but not to HFHL or sound hypersensitivity, potentially through vertical pleiotropy in individuals with non-Alzheimer's dementia.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.